GlassScriptPhysician profile
Clinton Michael Thome
NPI 1558654756
$5,198.82
in general payments reported to CMS, 2019-2025
29 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,700 · 2020: $341 · 2021: $528 · 2022: $580 · 2023: $798 · 2024: $894 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596 · Travel and Lodging: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.88 |
| Travel and Lodging | $455.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $1,349.50 | 2019 | |
| Nevro Corp. | $1,119.19 | 2019-2024 | Senza |
| Medtronic, INC. | $828.93 | 2021-2024 | Intellis Adaptivestim, Synchromedii, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $352.15 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Abbvie INC. | $259.42 | 2022-2025 | Ubrelvy, Qulipta |
| Pfizer INC. | $147.60 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $132.06 | 2023-2024 | Belbuca, Xtampza, Nucynta |
| Nalu Medical, INC. | $108.19 | 2021-2022 | |
| Abbott Laboratories | $95.00 | 2020 | |
| Globus Medical, INC. | $82.57 | 2025 | Vyrsa V1 |
| Si-Bone, INC. | $76.05 | 2023-2025 | |
| Medtronic USA, INC. | $68.33 | 2019-2020 | |
| Lilly USA, LLC | $63.78 | 2019-2023 | Emgality |
| Vertos Medical, INC. | $63.35 | 2022 | |
| Allergan, INC. | $54.76 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $50.57 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.35 | 2021-2025 | Relistor |
| Stimwave Technologies Incorporated | $48.93 | 2021-2022 | |
| Saluda Medical Americas, INC. | $37.02 | 2024-2025 | Evoke |
| Biodelivery Sciences International, INC. | $31.20 | 2019-2021 | |
| Amgen INC. | $28.89 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $27.57 | 2023 | Dysport |
| Biotronik Nro, INC. | $23.55 | 2025 | Prospera |
| Grt US Holding, INC. | $19.77 | 2022 | |
| Painteq LLC | $18.77 | 2022 | |
| Bioventus LLC | $17.78 | 2019 | |
| Pacira Therapeutics, INC. | $16.77 | 2019 | |
| Depuy Synthes Sales INC. | $14.00 | 2022 | |
| Spr Therapeutics, INC | $12.77 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Thome listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.